Lupeng Pharmaceutical Co., Ltd. submits a listing application to the Hong Kong Stock Exchange

Mars Finance News: According to a document from the Hong Kong Stock Exchange, Lufeng Pharmaceutical Co., Ltd. - B has submitted a listing application to the Hong Kong Stock Exchange, and CITIC Securities is the exclusive sponsor.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • 6
  • 2
  • Share
Comment
Add a comment
Add a comment
ThereAreCatsInTheContract.
· 4h ago
Being able to go public during an IPO winter is considered a skill
View OriginalReply0
PfpArchaeologist
· 4h ago
The sponsorship fee is probably another astronomical number.
View OriginalReply0
GateUser-c1cab702
· 4h ago
Look at the cash runway in the prospectus—how long can it last?
View OriginalReply0
GateUser-f49a50d4
· 4h ago
Now submitting the form, catching the year-end window period.
View OriginalReply0
L2AlleyRunner
· 4h ago
How is Lu Peng's progress on the BTK inhibitor?
View OriginalReply0
TheHiddenRisksBehindApy
· 4h ago
-The suffix B is standard for unprofitable biotech companies.
View OriginalReply0
  • Pinned